These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3235424)

  • 1. Measures of asthma severity recorded by patients.
    Kotses H; Harver A; Creer TL; Baker AD
    J Asthma; 1988; 25(6):373-6. PubMed ID: 3235424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the pulmonary score: an asthma severity score for children.
    Smith SR; Baty JD; Hodge D
    Acad Emerg Med; 2002 Feb; 9(2):99-104. PubMed ID: 11825832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should we monitor peak expiratory flow rates or record symptoms with a simple diary in the management of asthma?
    Malo JL; L'Archevêque J; Trudeau C; d'Aquino C; Cartier A
    J Allergy Clin Immunol; 1993 Mar; 91(3):702-9. PubMed ID: 8454792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twice-daily peak expiratory flow rate monitoring for the assessment of childhood asthma.
    Linna OV
    Allergy Proc; 1993; 14(1):33-6. PubMed ID: 8462860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using statistical process control charts for the continual improvement of asthma care.
    Boggs PB; Hayati F; Washburne WF; Wheeler DA
    Jt Comm J Qual Improv; 1999 Apr; 25(4):163-81. PubMed ID: 10228909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peak expiratory flow rate and symptom self-monitoring of asthma initiated from community pharmacies.
    Bheekie A; Syce JA; Weinberg EG
    J Clin Pharm Ther; 2001 Aug; 26(4):287-96. PubMed ID: 11493372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ozone and aeroallergens on the respiratory health of asthmatics.
    Ross MA; Persky VW; Scheff PA; Chung J; Curtis L; Ramakrishnan V; Wadden RA; Hryhorczuk DO
    Arch Environ Health; 2002; 57(6):568-78. PubMed ID: 12696655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of biofeedback-induced facial relaxation on measures of asthma severity in children.
    Kotses H; Harver A; Segreto J; Glaus KD; Creer TL; Young GA
    Biofeedback Self Regul; 1991 Mar; 16(1):1-21. PubMed ID: 2012823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Peak flow values in assessment of global improvement rating in bronchial asthma].
    Miyamoto T; Sawa J; Adachi T
    Arerugi; 1999 Jun; 48(6):576-88. PubMed ID: 10423898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Salt Space on Clinical Findings and Peak Expiratory Flow in Children with Mild to Moderate Asthma: A Randomized Crossover Trial.
    Mazloomzadeh S; Bakhshi N; Ahmadiafshar A; Gholami M
    Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):198-204. PubMed ID: 28732433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of fibreoptic bronchoscopy in asthmatic and control subjects and effect on asthma control over two weeks.
    Humbert M; Robinson DS; Assoufi B; Kay AB; Durham SR
    Thorax; 1996 Jul; 51(7):664-9. PubMed ID: 8882070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adequacy of control of asthma in a general practice. Is maximum peak expiratory flow rate a valid index of asthma severity?
    Morris NV; Abramson MJ; Strasser RP
    Med J Aust; 1994 Jan; 160(2):68-71. PubMed ID: 8309371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spirometric patterns in childhood asthma: peak flow compared with other indices.
    Klein RB; Fritz GK; Yeung A; McQuaid EL; Mansell A
    Pediatr Pulmonol; 1995 Dec; 20(6):372-9. PubMed ID: 8649917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of children's self-reported adherence to treatment.
    Burkhart PV; Dunbar-Jacob JM; Rohay JM
    J Nurs Scholarsh; 2001; 33(1):27-32. PubMed ID: 11253577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.
    Gustafsson P; Tsanakas J; Gold M; Primhak R; Radford M; Gillies E
    Arch Dis Child; 1993 Aug; 69(2):206-11. PubMed ID: 8215522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients.
    Tohda Y; Fujimura M; Taniguchi H; Takagi K; Igarashi T; Yasuhara H; Takahashi K; Nakajima S
    Clin Exp Allergy; 2002 Aug; 32(8):1180-6. PubMed ID: 12190656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peak expiratory flow rate and premenstrual symptoms in healthy nonasthmatic women.
    Chong E; Ensom MH
    Pharmacotherapy; 2000 Dec; 20(12):1409-16. PubMed ID: 11130212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of global questions versus health status questionnaires as measures of the severity and impact of asthma.
    Barley EA; Jones PW
    Eur Respir J; 1999 Sep; 14(3):591-6. PubMed ID: 10543280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
    Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
    Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Asian dust exposure and respiratory function in children with bronchial asthma in Nagasaki Prefecture, Japan.
    Nakamura T; Nishiwaki Y; Hashimoto K; Takeuchi A; Kitajima T; Komori K; Tashiro K; Hasunuma H; Ueda K; Shimizu A; Odajima H; Moriuchi H; Hashizume M
    Environ Health Prev Med; 2020 Mar; 25(1):8. PubMed ID: 32131724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.